iRadimed (IRMD)
(Real Time Quote from BATS)
$43.33 USD
+0.60 (1.40%)
Updated Jun 12, 2024 10:17 AM ET
3-Hold of 5 3
D Value B Growth B Momentum B VGM
Brokerage Reports
iRadimed Corporation [IRMD]
Reports for Purchase
Showing records 1 - 20 ( 173 total )
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
We reiterate our Buy rating and increase our target price to $61 from $58.
Provider: Singular Research
Analyst: DILORENZO F
Company: iRadimed Corporation
Industry: Medical - Instruments
We are updating our Healthcare coverage to reflect a recent analyst departure and to drop
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: iRadimed Corporation
Industry: Medical - Instruments
Optimized Entry and Exit Levels for IRMD 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
2Q23 Recap - Catalysts Forming for 2024 and 2025
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: iRadimed Corporation
Industry: Medical - Instruments
Company: iRadimed Corporation
Industry: Medical - Instruments
1Q23 Recap - Strong Momentum Continues; PT to $50
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S